Cargando…
A case of KMT2A–SEPT9 fusion–associated acute megakaryoblastic leukemia
Acute megakaryoblastic leukemia (AMKL) constitutes ∼5%–15% of cases of non–Down syndrome AML in children, and in the majority of cases, chimeric oncogenes resulting from recurrent gene rearrangements are identified. Based on these rearrangements, several molecular subsets have been characterized pro...
Autores principales: | Forlenza, Christopher J., Zhang, Yanming, Yao, JinJuan, Benayed, Ryma, Steinherz, Peter, Ramaswamy, Kavitha, Kessel, Rachel, Roshal, Mikhail, Shukla, Neerav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318764/ https://www.ncbi.nlm.nih.gov/pubmed/30455225 http://dx.doi.org/10.1101/mcs.a003426 |
Ejemplares similares
-
Clofarabine with topotecan, vinorelbine, and thiotepa reinduction regimen for children and young adults with relapsed AML
por: Ramaswamy, Kavitha, et al.
Publicado: (2022) -
Acute myeloid leukemia with an MN1-ETV6 fusion in a young child with Down syndrome
por: Rosenzweig, Jaclyn, et al.
Publicado: (2022) -
A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma
por: Wang, Weidong, et al.
Publicado: (2023) -
JAK2V617F and p53 mutations coexist in erythroleukemia and megakaryoblastic leukemic cell lines
por: Zhao, Wanke, et al.
Publicado: (2012) -
Myeloid/lymphoid neoplasms with eosinophilia/basophilia and ETV6-ABL1 fusion: cell-of-origin and response to tyrosine kinase inhibition
por: Yao, Jinjuan, et al.
Publicado: (2020)